NGS 2nd tier analysis, dried blood spots for LD (Request for Proposal)
Posted
Sep 4, 2026
Oct 13, 2026
Provide 2nd tier analysis of dried blood spots for lysosomal disorders via next-generation sequencing (ngs) for approximately 250 newborn screening specimens annually.
